| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EMR | Common Stock | Award | +13.6K | +16.48% | 95.8K | 04 Nov 2024 | Direct | F1, F2 | ||
| transaction | EMR | Common Stock | Tax liability | -$668K | -6.12K | -6.39% | $109.11 | 89.7K | 04 Nov 2024 | Direct | F3, F4 |
| transaction | EMR | Common Stock | Award | +13.2K | +14.7% | 103K | 04 Nov 2024 | Direct | F5, F6 | ||
| holding | EMR | Common Stock | 554 | 04 Nov 2024 | 401(k) excess plan |
| Id | Content |
|---|---|
| F1 | Acquisition of shares pursuant to Rule 16b-3 upon payout of 13,558 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2024. |
| F2 | Price is not applicable to the acquisition described in Note 1. |
| F3 | Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1. |
| F4 | Fair market value on date of withholding described in Note 1. |
| F5 | Grant to Reporting Person of 13,189 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
| F6 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |